Epoetin requirements predict mortality in hemodialysis patients
- 30 November 2004
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 44 (5) , 866-876
- https://doi.org/10.1053/j.ajkd.2004.08.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patientsKidney International, 2004
- The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patientsKidney International, 2003
- Confounding by Indication in Epidemiologic Studies of Commonly Used AnalgesicsClinical Journal of Sport Medicine, 2002
- Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathyKidney International, 2000
- High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patientsAmerican Journal of Kidney Diseases, 1997
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985